SEC Form 4 · accession 0001209191-15-079555
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric J. Rey
Officer — President and CEO · Director
Period of report
Nov 11, 2015
Accepted (ET)
Nov 12, 2015 · 11:11 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2015 | M | 3,000 | $1.08 | A | 142,630 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.08 | Nov 11, 2015 | M | 3,000 | D | — | Jun 30, 2018 | Common Stock | 3,000 | 622,000 | D |
Explanation of responses
- F1The option is fully exercisable as of the date hereof.